Bridger Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-18,778	Closed	-$7.35M	–	35
2025 Q3	$7.35M	Hold	18,778	–	–	3.96%	8
2025 Q2	$8.36M	Sell	18,778 -22,272	-54%	-$10.3M	4.93%	8
2025 Q1	$19.9M	Hold	41,050	–	–	9.89%	2
2024 Q4	$16.5M	Hold	41,050	–	–	8.88%	3
2024 Q3	$19.1M	Hold	41,050	–	–	9.55%	3
2024 Q2	$19.2M	Hold	41,050	–	–	9.9%	3
2024 Q1	$17.2M	Sell	41,050 -6,950	-14%	-$2.94M	7.74%	5
2023 Q4	$19.5M	Buy	48,000 +5,600	+13%	+$2.07M	7.49%	4
2023 Q3	$14.7M	Hold	42,400	–	–	5.4%	9
2023 Q2	$14.9M	Buy	+42,400	New	+$14.3M	4.95%	8
2023 Q1	–	Sell	-16,468	Closed	-$4.76M	–	31
2022 Q4	$4.76M	Sell	16,468 -23,304	-59%	-$7.1M	1.92%	18
2022 Q3	$11.5M	Sell	39,772 -33,300	-46%	-$9.58M	3.48%	10
2022 Q2	$20.6M	Sell	73,072 -9,728	-12%	-$2.6M	4.64%	8
2022 Q1	$21.6M	Buy	82,800 +23,400	+39%	+$5.55M	3.54%	13
2021 Q4	$13M	Buy	+59,400	New	+$11.6M	1.69%	22